Please try another search
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company’s pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Yiping Li | 59 | 2016 | Co-founder, Executive Chairman of the Board & CEO |
Yiu Leung Cheung | 63 | 2020 | Independent Non-Executive Director |
Xing Gao | 38 | 2020 | Non-Executive Director |
Ann Li Lee | 62 | 2020 | Independent Non-Executive Director |
Krishnan Viswanadhan | 45 | 2019 | Independent Non-Executive Director |
Cheng Liu | 56 | 2020 | Non-Executive Director |
Kin-Cheong Ho | 55 | 2020 | Independent Non-Executive Director |
Debra Yu | 58 | 2023 | Independent Non-Executive Director |
SungWon Song | 42 | 2023 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review